Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Clover Therapeutics Launches With Eye on Age-Related Ocular Diseases

Armed with mounds of patient data and a licensing deal with Genentech, Clover Therapeutics is ready to tackle the development of potential therapies for age-related ocular diseases.

Read More »

Japan’s Astellas Acquires U.K.-Based Quethera

Astellas Pharma Inc. plunked down nearly $109 million to snap up privately held Quethera Ltd. and the gene therapy company’s novel treatments for glaucoma and other ocular disorders.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom